Recent Finacing
Recent Raise
Curve Therapeutics develops an intracellular Microcycle® platform to screen hexameric cyclic peptide libraries in mammalian cells, convert hits to small molecules, and advance oncology HIF/ATIC inhibitor programs with MSD.